NCT05291351Completed
Impact of Pea, Lentil and Oat Flour Particle Size on Glycemic Response in Healthy Adults
Comparison of the Impacts of Pea, Lentil, and Oat Flour Particle Size on Postprandial Glycemic Response and Appetite in Healthy Adults
Source: ClinicalTrials.gov · Last updated 5 Jul 2024
Brief summary (registry, in English)
The study looks at the comparative effects of food products made with pea, lentil, and oat flour of various particle sizes on postprandial glycemic response, appetite and food intake, and amino acid release in healthy adults.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 28 Feb 2022
- Start date
- 1 Apr 2022
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- University of Toronto
- Diseases
- Obesity
- NCT number
- NCT05291351
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 1 Apr 2022 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous history of cardiovascular disease, diabetes, liver or kidney disease, inflammatory bowel disease, celiac disease, short bowel syndrome, a malabsorptive syndrome, pancreatitis, gallbladder or biliary disease.
- Weight gain or loss of at least 10lbs in previous three months.
Other illness
- Presence of a gastrointestinal disorder or surgeries within the past year.
- Allergies to peanuts and nuts.
- Known intolerances, sensitivity or allergy to any ingredients in the study products: pea flour, lentil flour, oat flour and whole wheat flour.
- Uncontrolled hypertension (systolic blood pressure \> 140 mm Hg or diastolic blood pressure \> 90 mm Hg) as defined by the average blood pressure measured at screening.
Lab values
- Consuming prescription or non-prescription drug, herbal or nutritional supplements known to affect blood glucose or that could affect the outcome of the study as per investigator's judgment.
Other
- Smoking
- Thyroid problems
- Known to be pregnant or lactating.
- Unwillingness or inability to comply with the experimental procedures and to follow our safety guidelines.
- Regular breakfast skipping (consumes breakfast less than 5 days a week)
- Extreme dietary habits (i.e Atkins diet, very high protein diets, etc.) or restrained eaters, identified by a score of ≥ 11 on the Eating Habits Questionnaire
- Excessive alcohol intake (more than 2 drinks per day or more than 9 drinks per week).
Who the study is looking for
- 18-45 years of age
- BMI 18.5-29.9 kg/m2
- Willing to maintain habitual diet, physical activity pattern, and body weight throughout the trial.
- Willing to maintain current dietary supplement use throughout the trial.
- Willing to abstain from alcohol consumption for 24h prior to all test visits.
- Willing to avoid vigorous physical activity for 24h prior to all test visits.
- Understanding the study procedure and willing to provide informed consent to participate in the study and authorization to release relevant protected health information to the study investigator.
Age in the registry: 18 years to 45 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Nutritional Sciences Coordinator of this site? Confirm its status | Toronto | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.